News

Blog Post

Italy: Formulation patents may prevent reimbursement of generics… but, are you innovative enough?

The possibility for the patent owner to prevent the reimbursement of medicinal products before expiry of patent protection is still an open issue. While the law covers prohibition of...

Blog Post

Pharma advertising in Italy – Online publication of OTC medicinal products list, prices and reimbursability

The Court of Milan held in a Judgment recently handed down in the proceedings brought by Bayer S.p.a. against the generic manufacturer DOC Generici S.r.l. that online publication of...

Blog Post

Italy opens the door to corporate ownership of pharmacies – a revolution for the Italian Pharma distribution

By Law passed today, 2 August 2017 (Law for the improvement of the competition on the market), further to a recommendation of the Italian Competition Authority (“ICA“), the...

Blog Post

Italian time-machine : Limitation of the duration of an SPC may be decided by the Italian Patent Office

The Board of Appeal of the Italian Patent Office (Commissione dei Ricorsi), by decision published on June 26, 2017, acknowledged the right of the patent holder to ask the Italian Patent...

Press Releases

Hogan Lovells assists Helsinn Investment Fund, lead investor of the round, in its €2 million investment in the Italian start-up GreenBone Ortho S.r.l.

Hogan Lovells assisted Helsinn Investment Fund S.A., backed by the Swiss pharmaceutical group Helsinn and focused on supporting early stage opportunities in areas of high unmet patient...

Blog Post

Court of Milan rules on interim measure ordering the halt of the pricing and reimbursement procedure of a generic product

By order issued on June 18, 2017, in summary proceedings brought by Teva against Mylan and Synthon for the alleged infringement of EP 2 361 924 (covering a manufacturing process for the...

Loading data